• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNKPROWLER; MICROCATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNKPROWLER; MICROCATHETER Back to Search Results
Catalog Number UNKPROWLER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); High Blood Pressure/ Hypertension (1908); Perforation of Vessels (2135)
Event Date 09/03/2014
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).Literature citation: ¿diabetes mellitus does not increase the risk of adverse long-term outcomes after intracranial stent placement¿ reviewed.Li bh, yin yw, gao cy, hu zc, wang jh, zhang ll, li jc.Cell biochem biophys.2015 jan;71(1):413-8.Doi: 10.1007/s12013-014-0214-z.Pmid: 25182003.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.
 
Event Description
Literature article ¿diabetes mellitus does not increase the risk of adverse long-term outcomes after intracranial stent placement¿ reviewed.Li bh, yin yw, gao cy, hu zc, wang jh, zhang ll, li jc.Cell biochem biophys.2015 jan;71(1):413-8.Doi: 10.1007/s12013-014-0214-z.Pmid: 25182003.Objective and methods: ¿the present study is to investigate whether diabetes mellitus (dm) increases risk of adverse long-term outcomes after intracranial stent placement.Patients receiving intracranial stenting were assigned to dm group and non-dm group according to diabetes status.¿ ¿a total of 44 stenoses in 43 patients were retrospectively analyzed.¿ ¿after adjusting for the confounders, the risk of dm versus non-dm for composite outcomes remained insignificant.¿ ¿there is no evidence that dm increases the risk of adverse long-term outcomes after intracranial stent placement¿.Lot, model and catalog number are not available, but the suspected cerenovus device possibly associated with reported adverse events: prowler14 microcatheter cordis, 6f-guiding catheter envoy cordis.Other cerenovus devices that were also used in this study: n/a.Non-cerenovus devices that were also used in this study: 0.01400 micro-guide wire, wizdom, 0.01400 micro-guide wire, transcend-14, balloon catheters ryujinplus, terum, balloon-expandable stents, apollo, microport, guidant mimi vision, guidant, clearflex, clenrstream.Invastent, volo.Adverse event(s) and provided interventions: intracranial hemorrhage, hyperfusion postoperation, vessel perforation intra-op, specific interventions were not provided per adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKPROWLER
Type of Device
MICROCATHETER
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN & SHURTLEFF, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvarcar
juarez chihuahua 32574
MX   32574
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12574111
MDR Text Key274705210
Report Number3008114965-2021-00496
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K003925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKPROWLER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/09/2021
Initial Date FDA Received10/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0.01400 MICRO-GUIDE WIRE, TRANSCEND-14; 0.01400 MICRO-GUIDE WIRE, WIZDOM; BALLOON CATHETERS RYUJINPLUS, TERUM; BALLOON-EXPANDABLE STENTS, APOLLO, MICROPORT; CLEARFLEX, CLENRSTREAM; GUIDANT MIMI VISION, GUIDANT; INVASTENT, VOLO
Patient Outcome(s) Life Threatening;
-
-